Table 1.
Patient demographic and pathological data.
Age (Median) | 76 (55–85) |
Sex (M:F) | 10:8 |
BMI (Mean) | 26.6 (21–39) |
Anatomical location | |
Ascending colon | 16 |
Descending colon | 2 |
T stage | |
T0 (TVAs) | 3 |
T1 | 1 |
T2 | 1 |
T3 | 5 |
T4 | 8 |
N stage | |
N0 | 11 |
N1 | 4 |
N2 | 3 |
Histological subtype | |
Adenocarcinoma | 15 |
Dysplasia | 3 |
Differentiation | |
Well | 1 |
Moderate | 11 |
Poor | 6 |
Perineural invasion | 1 |
Lymphovascular invasion (LVI) | 6 |
Extramural vascular invasion (EMVI) | 5 |
KRAS mutants | 2 |
BMI: Body Mass Index; TVA: Tubulovillous adenoma; KRAS: Kirsten rat sarcoma viral oncogene homolog.